初代細胞培養の世界市場：市場規模・シェア・動向分析 (製品別・細胞の種類別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

初代細胞培養市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の初代細胞培養の市場規模は2030年までに86億7,000万米ドルに達すると予測されています。

同市場は、2025年から2030年にかけてCAGR 10.55％で成長すると予測されています。個別化治療や精密治療に対する需要の高まりが、より正確で関連性の高いin vitroモデルの必要性を煽っています。初代細胞培養は、従来の細胞株と比較してヒトの生物学や生理学をより忠実に再現することができるため、疾病メカニズムの研究、創薬、治療法開発に不可欠なツールとなっています。治療薬候補の成功率を向上させ、コストのかかる後期段階での失敗を減らし、最終的には患者により効果的で的を絞った治療法を提供するために、1次細胞培養の重要性を認識する研究者や製薬会社が増えています。

さらに、再生医療の分野では、損傷した組織や臓器の置換や修復を目指しており、初代細胞培養は、機能的組織の開発や工学化において重要な役割を果たしています。初代細胞は、組織構築物、オルガノイド、生体工学的インプラントなど、本来の組織の構造や機能を忠実に模倣したものを作製するために使用されます。これらの進歩は、組織移植、創傷治癒、変性疾患の治療などの再生医療治療に大きな影響を与えます。例えば、2023年4月、マウントサイナイは、新たな発見を育み、生命を脅かす疾患に対する新たな治療法を探求するために、再生医療のための新しい研究所を立ち上げました。再生医療への関心の高まりと医療に革命をもたらす可能性が、初代細胞培養への投資と研究の増加につながり、市場の成長を後押ししています。

COVID-19パンデミックは初代細胞培養産業に大きな影響を与えました。パンデミックは医療や研究を含む様々な産業を混乱させたが、ウイルスを理解し治療法を開発する上で初代細胞培養の重要な役割を浮き彫りにしました。初代細胞は、SARS-CoV-2感染のメカニズムの研究、抗ウイルス療法の試験、ワクチンの有効性の評価に役立っています。パンデミックは、世界中の研究者がCOVID-19関連の研究に注力する中、初代細胞培養製品およびサービスの需要を加速させました。

さらに、主要市場参入企業によるいくつかの開発や産学連携の増加が世界市場を牽引しています。例えば、2023年1月には、Bio-TracとATCCが共同で、初代細胞培養の原理、オルガノイドとスフェロイド、その他の関連する細胞培養技術の概要を提供するトレーニングワークショップを実施しました。

初代細胞培養市場：分析概要

• 製品別では、試薬・サプリメントのセグメントが2024年に37.7%のシェアを占めました。これは、特定の細胞タイプや研究用途に合わせた高品質の試薬・サプリメントが幅広く入手可能なためです。
• 分離方法別では、酵素分解分野が2024年に32.15%のシェアで市場を独占しました。この方法の利点は、培養物へのダメージが少ないこと、所要時間が比較的短いこと、サンプルの分取量が多いことなどです。
• 細胞の種類別では、動物細胞セグメントが予測期間中に高成長が見込まれています。このセグメントの高い成長は、この細胞タイプの汎用性、幅広い入手可能性、確立された研究プロトコールに起因しています。
• 北米は、高度に発達した医療インフラと有利な政府政策により、2024年には41.58%のシェアを獲得し、世界市場で強い地域地位を確立しました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 初代細胞培養市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 初代細胞培養市場：製品別のビジネス分析

• セグメントダッシュボード：製品別
• 世界の初代細胞培養市場：変動分析、製品別
• 世界の初代細胞培養の市場規模と動向分析：製品別 (2018～2030年)
• 初代細胞
• 培地
• 試薬・サプリメント

第5章 初代細胞培養市場：用途別のビジネス分析

• セグメントダッシュボード：用途別
• 世界の初代細胞培養市場：変動分析、用途別
• 世界の初代細胞培養の市場規模と動向分析：用途別 (2018～2030年)
• ワクチン製造
• 細胞・遺伝子治療薬の開発
• モデルシステム
• ウイルス学
• 出生前診断
• その他の用途

第6章 初代細胞培養市場：細胞の種類別のビジネス分析

• セグメントダッシュボード：細胞の種類別
• 世界の初代細胞培養市場：変動分析、細胞の種類別
• 世界の初代細胞培養の市場規模と動向分析：細胞の種類別 (2018～2030年)
• ヒト細胞
• 動物細胞

第7章 初代細胞培養市場： 最終用途別のビジネス分析

• セグメントダッシュボード：最終用途別
• 世界の初代細胞培養市場：変動分析、最終用途別
• 世界の初代細胞培養の市場規模と動向分析：最終用途別 (2018～2030年)
• 製薬・バイオテクノロジー企業
• CMO・CRO
• 学術研究機関

第8章 初代細胞培養市場：地域別の推定・動向分析（製品別・用途別・最終用途別）

• 地域ダッシュボード
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析（2024年）
• 参入企業の概要
  • Thermo Fisher Scientific Inc.
  • STEMCELL Technologies
  • Merck KGaA
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell GMBH
  • ZenBio
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd.

List of Tables

• Table 1 List of abbreviations
• Table 2 Primary Cell Culture market, by product, 2018 - 2030 (USD Million)
• Table 3 Primary Cell Culture market, by end use, 2018 - 2030 (USD Million)
• Table 4 Primary Cell Culture market, by cell type, 2018 - 2030 (USD Million)
• Table 5 Primary Cell Culture market, by application, 2018 - 2030 (USD Million)
• Table 6 Primary Cell Culture market, by region, 2018 - 2030 (USD Million)
• Table 7 North America primary cell culture market, by country, 2018 - 2030 (USD Million)
• Table 8 North America primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 9 North America primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 10 North America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 11 North America primary culture market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 13 U.S. primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 14 U.S. primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 15 U.S. primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 16 Canada primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 17 Canada primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 18 Canada primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 19 Canada primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 20 Mexico primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 21 Mexico primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 22 Mexico primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 23 Mexico primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 24 Europe primary cell culture market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 26 Europe primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 27 Europe primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 28 Europe primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 29 UK primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 30 UK primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 31 UK primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 32 UK primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 33 Germany primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 34 Germany primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 35 Germany primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 36 Germany primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 37 France primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 38 France primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 39 France primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 40 France primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 41 Italy primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 42 Italy primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 43 Italy primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 44 Italy primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 45 Spain primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 46 Spain primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 47 Spain primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 48 Spain primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 49 Denmark primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 50 Denmark primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 51 Denmark primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 52 Denmark primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 53 Sweden primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 54 Sweden primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 55 Sweden primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 56 Sweden primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 57 Norway primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 58 Norway primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 59 Norway primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 60 Norway primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific primary cell culture market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 66 Japan primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 67 Japan primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 68 Japan primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 69 Japan primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 70 China primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 71 China primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 72 China primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 73 China primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 74 India primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 75 India primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 76 India primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 77 India primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 78 Australia primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 79 Australia primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 80 Australia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 81 Australia primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 82 Thailand primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 83 Thailand primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 84 Thailand primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 85 Thailand primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 86 South Korea primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 87 South Korea primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 88 South Korea primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 89 South Korea primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 90 Latin America primary cell culture market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 92 Latin America primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 93 Latin America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 94 Latin America primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 95 Brazil primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 96 Brazil primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 97 Brazil primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 98 Brazil primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 99 Argentina primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 100 Argentina primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 101 Argentina primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 102 Argentina primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 103 Middle East & Africa primary cell culture market, by country, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 108 South Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 110 South Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 111 South Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 116 UAE primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 117 UAE primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 118 UAE primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 119 UAE primary cell culture market, by application, 2018 - 2030 (USD Million)
• Table 120 Kuwait primary cell culture market, by product, 2018 - 2030 (USD Million)
• Table 121 Kuwait primary cell culture market, by end use, 2018 - 2030 (USD Million)
• Table 122 Kuwait primary cell culture market, by cell type, 2018 - 2030 (USD Million)
• Table 123 Kuwait primary cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Primary Cell Culture market segmentation
• Fig. 7 Market snapshot, 2024
• Fig. 8 Market trends & outlook
• Fig. 9 Market driver relevance analysis
• Fig. 10 Market restraint relevance analysis
• Fig. 11 PESTEL analysis
• Fig. 12 Porter's five forces analysis
• Fig. 13 Primary Cell Culture market: Product movement analysis
• Fig. 14 Primary Cell Culture market, for primary cells, 2018 - 2030 (USD Million)
• Fig. 15 Primary Cell Culture market, for reagents and supplements, 2018 - 2030 (USD Million)
• Fig. 16 Primary Cell Culture market, for media, 2018 - 2030 (USD Million)
• Fig. 17 Primary Cell Culture market: end use movement analysis
• Fig. 18 Primary Cell Culture market, for pharmaceutical and biotechnology companies
• Fig. 19 Primary Cell Culture market, for CMOs & CROs
• Fig. 20 Primary Cell Culture market, for Academic Research Institutes
• Fig. 21 Primary Cell Culture market: Cell Type movement analysis
• Fig. 22 Primary Cell Culture market, for animal cells, 2018 - 2030 (USD Million)
• Fig. 23 Primary Cell Culture market, for human cells, 2018 - 2030 (USD Million)
• Fig. 24 Primary Cell Culture market: Application movement analysis
• Fig. 25 Primary Cell Culture market, for cell & gene therapy development, 2018 - 2030 (USD Million)
• Fig. 26 Primary Cell Culture market, for vaccine production, 2018 - 2030 (USD Million)
• Fig. 27 Primary Cell Culture market, for model system, 2018 - 2030 (USD Million)
• Fig. 28 Primary Cell Culture market, for virology, 2018 - 2030 (USD Million)
• Fig. 29 Primary Cell Culture market, for prenatal diagnosis, 2018 - 2030 (USD Million)
• Fig. 30 Primary Cell Culture market, for others applications, 2018 - 2030 (USD Million)
• Fig. 31 Regional marketplace: Key takeaways
• Fig. 32 Regional outlook, 2024 & 2030
• Fig. 33 Primary Cell Culture market: Region movement analysis
• Fig. 34 North America Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 36 Canada Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 37 Mexico Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 38 Europe Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 39 Germany Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 40 UK Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 41 France Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 42 Italy Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 43 Spain Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 44 Denmark Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 45 Sweden Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 46 Norway Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 47 Asia Pacific Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 48 Japan Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 49 China Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 50 India Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 51 Australia Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 52 South Korea Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 53 Thailand Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 54 Latin America Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 55 Brazil Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 56 Argentina Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 57 Middle East and Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 58 South Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 59 Saudi Arabia Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 60 UAE Primary Cell Culture market, 2018 - 2030 (USD Million)
• Fig. 61 Kuwait Primary Cell Culture market, 2018 - 2030 (USD Million)

Primary Cell Culture Market Growth & Trends:

The global primary cell culture market size is anticipated to reach USD 8.67 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.55% from 2025 to 2030. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market's growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

Primary Cell Culture Market Report Highlights:

• By product, the reagent and supplements segment dominated with a share of 37.7% in 2024, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
• By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2024, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
• By cell type, the animal cells segment is expected to grow lucratively over the forecast period. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
• North America established a strong regional position in the global market with a 41.58% share in 2024 due to its highly developed healthcare infrastructure and favorable government policies

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Cell Type Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
    • 3.2.1.2. Increasing in demand for stem cell therapy and regenerative medicine
    • 3.2.1.3. Rising incidence of cancer and other chronic diseases
    • 3.2.1.4. Advancement in genetic engineering protocols
    • 3.2.1.5. Rise in research funding for functional biology and research
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Ethical and regulatory concerns related with the use of primary cells
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Primary Cell Culture Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Primary Cell Culture Market Product Movement Analysis
• 4.3. Global Primary Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Primary Cells
  • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Hematopoietic Cells
    • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Skin Cells
    • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Hepatocytes
    • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Gastrointestinal Cells
    • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Lung Cells
    • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Renal Cells
    • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.8. Heart Cells
    • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.9. Skeletal and Muscle Cells
    • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.10. Other Primary Cells
    • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Media
  • 4.5.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Serum-free Media
    • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Serum-containing Media
    • 4.5.3.1. Global Serum-containing Media Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Other Media
    • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Reagents and Supplements
  • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Attachment Solutions
    • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Buffers and Salts
    • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.4. Sera
    • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.5. Growth Factors and Cytokines
    • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.6. Freezing Media
    • 4.6.6.1. Global Freezing Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.7. Others
    • 4.6.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Primary Cell Culture Market Application, Movement Analysis
• 5.3. Global Primary Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Vaccine Production
  • 5.4.1. Global Vaccine Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cell & Gene Therapy Development
  • 5.5.1. Global Cell & Gene Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Model System
  • 5.6.1. Global Model System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Virology
  • 5.7.1. Global Virology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Prenatal Diagnosis
  • 5.8.1. Global Prenatal Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Other Applications
  • 5.9.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: Cell Type Business Analysis

• 6.1. Cell Type Segment Dashboard
• 6.2. Global Primary Cell Culture Market Cell Type Movement Analysis
• 6.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Human Cells
  • 6.4.1. Global Human Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Animal Cells
  • 6.5.1. Global Animal Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Primary Cell Culture Market End Use Movement Analysis
• 7.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. CMOs & CROs
  • 7.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Academic Research Institutes
  • 7.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Participant's Overview
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. STEMCELL Technologies
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Merck KGaA
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Lonza
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Cell Biologics, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. PromoCell GMBH
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. ZenBio
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. AllCells
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. American Type Culture Collection
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Axol Biosciences Ltd.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives